Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.

BACKGROUND & AIMS The primary aim of this study was to compare the rate of global radiofrequency ablation (RFA) failure between monopolar RFA (MonoRFA) vs. no-touch multi-bipolar RFA (NTmbpRFA) for small hepatocellular carcinoma (HCC) ⩽5cm in cirrhotic patients. METHODS A total of 362 cirrhotic patients were included retrospectively across four French centres (181 per treatment group). Global RFA failure (primary RFA failure or local tumour progression) was analysed using the Kaplan-Meier method after coarsened exact matching. Cox regression models were used to identify factors associated with global RFA failure and overall survival (OS). RESULTS Patients were well matched according to tumour size (⩽30/>30mm); tumour number (one/several); tumour location (subcapsular and near large vessel); serum AFP (<10; 10-100; >100ng/ml); Child-Pugh score (A/B) and platelet count (</⩾100G/L), p=1 for all. One case of perioperative mortality was observed in the NTmbpRFA group and the rate of major complications was 7.2% in both groups (p=1). The cumulative rates of global RFA failure at 1, 3 and 5years were respectively 13.3%, 31% and 36.7% for MonoRFA vs. 0.02%, 7.9% and 9.2% for NTmbpRFA, p<0.001. Monopolar RFA, tumour size >30mm and HCC near large vessel were independent factors associated with global RFA failure. Five-year OS was 37.2% following MonoRFA vs. 46.4% following NTmbpRFA p=0.378. CONCLUSIONS This large multicentre case-matched study showed that NTmbpRFA provided better primary RFA success and sustained local tumour response without increasing severe complications rates, for HCC ⩽5cm. LAY SUMMARY Using no-touch multi-bipolar radiofrequency ablation for hepatocellular carcinoma ⩽5cm provide a better sustained local tumour control compared to monopolar radiofrequency ablation.

[1]  G. Dodd,et al.  Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. , 2001, AJR. American journal of roentgenology.

[2]  S. Morita,et al.  Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma , 2010, Cancer.

[3]  Nicolas Sellier,et al.  Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. , 2016, Radiology.

[4]  S. Joffe,et al.  Equipoise and the dilemma of randomized clinical trials. , 2011, The New England journal of medicine.

[5]  Yukio Iwashita,et al.  Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma , 2005, Cancer.

[6]  Sheung Tat Fan,et al.  Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. , 2008, Journal of the American College of Surgeons.

[7]  C. Aubé,et al.  Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar? , 2016, Journal of gastroenterology and hepatology.

[8]  Donald L. Miller,et al.  Society of Interventional Radiology clinical practice guidelines. , 2009, Journal of vascular and interventional radiology : JVIR.

[9]  Sheng-Nan Lu,et al.  Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. , 2012, Journal of hepatology.

[10]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[11]  M. Montaudon,et al.  Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients , 2015, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[13]  Arun J. Sanyal,et al.  非アルコール性脂肪肝炎の治療薬およびバイオマーカーの開発における課題と機会 : 米国肝臓病学会(American Association for the Study of Liver Diseases)と米国食品医薬品局の合同ワークショップの知見と推奨 , 2015 .

[14]  M. Choi,et al.  Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. , 2013, Journal of hepatology.

[15]  M. Lee,et al.  Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. , 2014, Radiology.

[16]  M. Pompili,et al.  Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[17]  X. Qu,et al.  Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation. , 2015, World journal of gastroenterology.

[18]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[19]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[20]  Joon Koo Han,et al.  Multiple-Electrode Radiofrequency Ablation of In Vivo Porcine Liver: Comparative Studies of Consecutive Monopolar, Switching Monopolar Versus Multipolar Modes , 2007, Investigative radiology.

[21]  J. Cardella,et al.  Society of Interventional Radiology clinical practice guidelines. , 2003, Journal of vascular and interventional radiology : JVIR.

[22]  Y. Paik,et al.  Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance. , 2015, Radiology.

[23]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Radiology.

[24]  P. Nahon,et al.  Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. , 2016, Radiology.

[25]  E. Vicaut,et al.  Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria. , 2014, Journal of vascular and interventional radiology : JVIR.

[26]  P. Liang,et al.  Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up. , 2014, European journal of radiology.

[27]  Chun-Jen Liu,et al.  Multipolar radiofrequency ablation with non‐touch technique for hepatocellular carcinoma ≤ 3 cm: A preliminary report , 2014 .

[28]  M. Sherman,et al.  Needle tract seeding after radiofrequency ablation of hepatic tumors. , 2005, Journal of vascular and interventional radiology : JVIR.

[29]  K. Sung,et al.  Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone , 2011, Annals of Surgical Oncology.

[30]  W. Lau,et al.  Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma: A Prospective Randomized Trial , 2007, Annals of surgery.

[31]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[32]  Aggressive Intrasegmental Recurrence of Periportal Hepatocellular Carcinoma after Radiofrequency Ablation: Role of Ablative Technique and Heat-Sink Effect? , 2015, Radiology.

[33]  G. King,et al.  Cem: Coarsened Exact Matching in Stata , 2009 .

[34]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[35]  O. Seror,et al.  Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients. , 2008, Radiology.

[36]  M. Pompili,et al.  Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma , 2013 .